About CELLECTAR BIOSCIENCES, INC
Cellectar Biosciences, Inc. is a biotechnology company focused on developing precision cancer therapies using its proprietary Phospholipid Drug Conjugate (PDC) platform. The company aims to deliver targeted treatments that minimize harm to healthy tissue and improve outcomes for patients with advanced cancers.
Development of precision medicine and personalized cancer treatmentsUtilization of a novel Phospholipid Drug Conjugate (PDC) platform for targeted delivery of oncology therapeuticsDelivery of therapeutic modalities including radioisotopes, small molecule cytotoxins, and biologics to tumor cells
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CELLECTAR BIOSCIENCES, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.